Coronary Artery Disease Global Market Research Report 2023
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease Global Market Report 2023" report has been added to * ResearchAndMarkets.com's* offering.
The global coronary artery disease market is expected to grow from $23.85 billion in 2022 to $26.30 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The coronary artery disease market is expected to reach $38.27 billion in 2027 at a CAGR of 9.8%.
The coronary artery disease market research report provides coronary artery disease market statistics, including coronary artery disease industry global market size, regional shares, competitors with a coronary artery disease market share, detailed coronary artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery disease industry.
Technological advancements are key trends gaining traction in the coronary artery disease market. Major companies operating in the coronary artery disease sector are focused on developing technologically advanced solutions to strengthen their position in the market.
For instance, in June 2020, iVascular S.L.U., a Spain-based medical device company, launched the Essential Pro, a novel reliable drug-coated balloon with hydrophilic coating technology applied in the distal shaft to reduce friction during navigation. It has superior safety, fast deflation times, better usability, visibility, and trackability.
It dilates stenosis, coronary artery, and bypass graft occlusions. In April 2023, Abbott Laboratories, a US-based medical devices, and healthcare company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition aims to provide Abbott with a complementary solution for treating vascular disease.
Cardiovascular Systems Inc. is a US-based medical device company specializing in developing and commercializing innovative solutions for treating peripheral and coronary artery disease. The rise in the prevalence of coronary artery disease is also expected to propel the growth of the coronary artery disease market over the coming years.
Coronary artery disease (CAD) is a medical condition characterized by the narrowing or blockage of the coronary arteries, which supply blood to the heart muscle. Coronary artery disease cases are increasing due to increased changes in diet, stress, lack of exercise, obesity, age, and others.
Coronary artery disease is treated with drugs using clopidogrel, ticagrelor, warfarin, and heparin and with procedures such as coronary artery bypass grafting, angioplasty, and stenting. The rise in the prevalence of coronary artery disease is expected to boost the coronary artery disease market during the forecast period.
North America was the largest region in the coronary artery disease market in 2022. The countries covered in the coronary artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
*Key Attributes:*
*Report Attribute* *Details*
No. of Pages 175
Forecast Period 2023 - 2027
Estimated Market Value (USD) in 2023 $26.3 billion
Forecasted Market Value (USD) by 2027 $38.27 billion
Compound Annual Growth Rate 9.8%
Regions Covered Global
*Key Topics Covered:*
*1. Executive Summary*
*2. Coronary Artery Disease Market Characteristics*
*3. Coronary Artery Disease Market Trends And Strategies*
*4. Coronary Artery Disease Market - Macro Economic Scenario*
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Coronary Artery Disease Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Coronary Artery Disease Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Coronary Artery Disease Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
*6. Coronary Artery Disease Market Segmentation*
6.1. Global Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
· Medication
· Surgery
· Additional Therapy
· Other Treatments
6.2. Global Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
· Electrocardiogram
· Echocardiogram
· Stress Test
· Cardiac Catheterization
· Heart CT Scan
· Other Diagnosis
6.3. Global Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Other Channels
6.4. Global Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
· Hospitals
· Specialty Clinics
· Other End-Users
*7. Coronary Artery Disease Market Regional And Country Analysis*
7.1. Global Coronary Artery Disease Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Coronary Artery Disease Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
*A selection of companies mentioned in this report includes*
· Pfizer Inc.
· Merck & Co. Inc.
· AbbVie Inc.
· Bayer AG
· Novartis AG
· Sanofi S.A.
· Bristol-Myers Squibb Company
· AstraZeneca plc
· Abbott Laboratories
· GlaxoSmithKline plc
· Gilead Sciences Inc.
· Amgen Inc.
· Viatris Inc.
· Teva Pharmaceutical Industries Ltd.
· Aurobindo Pharma Ltd.
· Hikma Pharmaceuticals plc
· Amneal Pharmaceuticals Inc.
· Chiesi Farmaceutici S.p.A.
· Lupin Pharmaceuticals Inc.
· Wockhardt Ltd.
· Honya Medical Inc.
· Idorsia Pharmaceuticals Ltd.
· Cytokinetics Inc.
· Kowa Pharmaceuticals America Inc.
· Sinotau Pharmaceutical Group
· HRV Global Life Sciences
· Barr Pharmaceuticals Inc.
· AdvanceCor GmbH
· Deutsches Zentrum fur Herz- Kreislauf-Forschung (DZHK) e.V.
For more information about this report visit https://www.researchandmarkets.com/r/8m0bqw
*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
*Attachment*
· Global Coronary Artery Disease Market
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900